TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/20/24 18:04 | 2/15/24 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | DO | P,CEO | M.d | 0 | 0.00 | 0 | 42 | 4 | 1,078 | D | ||||||||||||||
6/2/23 16:10 | 6/1/23 | GLYC | Glycomimetics Inc | DE | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | D | M.d | 13 | 0.6000 | 0 | 21 | 133 | 37 | D | |||||||||||||||
1/30/23 16:13 | 1/27/23 | GLYC | Glycomimetics Inc | DE | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | D | M.d | 27 | 2.55 | 0 | 11 | 200 | 16 | D | |||||||||||||||
5/17/22 17:20 | 5/16/22 | MGNX | Macrogenics Inc | DE | Health | Drug | Pharmaceutical Preparations | Koenig Scott | MD | DO | P,CEO | M.d | 80 | 1.51 | 0 | 53 | 5 | 1,050 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |